Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China
Authors:
Open Access
- 6 July 2020
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (2) , 1238-1246
Abstract
Purpose: To evaluate the oncologic efficacy and feasibility of nephron-sparing surgery (NSS) in adult Xp11.2 translocation renal cell carcinoma (RCC). Patients and Methods: Seventy patients with Xp11.2 translocation RCC and 273 with conventional RCC from five institutions in Nanjing were retrospectively studied. All patients were older than 18 years and were categorized into clinical T1 (cT1) stage using preoperative imaging. Using the preoperative imaging and electronic medical records, anatomical and pathological features were collected and analyzed. Results: Among patients with Xp11.2 translocation RCC, 18/36 (50.0%) with cT1a and 12/34 (35.3%) with cT1b tumors underwent NSS. The respective proportions in the conventional RCC group were 121/145 (83.4%) and 93/128 (72.7%). Among cT1a tumors, the Xp11.2 translocation RCCs tended to be adjacent to the collecting system, sinus, and axial renal midline compared with conventional RCCs. Patients with Xp11.2 translocation RCCs who underwent NSS had comparable progression-free survival (PFS) and overall survival to radical nephrectomy (RN) patients (P > 0.05). Among cT1b tumors, surgical margin positivity and pelvicalyceal, vascular, and region lymphatic involvement were more likely to occur in the Xp11.2 translocation RCCs (P < 0.05). Patients with Xp11.2 translocation RCC who underwent RN had a more favorable PFS than those who underwent NSS (P = 0.048). However, multivariate analysis of PFS did not identify surgical method as a risk factor (P = 0.089). Conclusions: Among adults with Xp11.2 translocation RCC, NSS can be an alternative for patients with cT1a tumor but should be performed with more deliberation in patients with cT1b tumors.Keywords
Funding Information
- Beijing Ronghe Medical Development Foundation
- National Natural Science Foundation of China (81572512)
- Nanjing SCI-TECH Development Project (201803025)
This publication has 48 references indexed in Scilit:
- Tumor Complexity Predicts Malignant Disease for Small Renal MassesJournal of Urology, 2012
- External Validation of a Nomogram Using RENAL Nephrometry Score to Predict High Grade Renal Cell CarcinomaJournal of Urology, 2012
- Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry ScoreEuropean Urology, 2011
- Xp11.2 Translocation Renal Cell Carcinomas Have a Poorer Prognosis Than Non-Xp11.2 Translocation Carcinomas in Children and Young Adults: A Meta-analysisInternational Journal of Surgical Pathology, 2010
- The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and DepthJournal of Urology, 2009
- Pediatric Renal Cell CarcinomaAmerican Journal of Clinical Pathology, 2006
- 2004 WHO Classification of the Renal Tumors of the AdultsEuropean Urology, 2006
- Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinomaCancer, 2004
- PRCC-TFE3 Renal CarcinomasAmerican Journal of Surgical Pathology, 2002
- NEPHRON SPARING SURGERY FOR RENAL TUMORS: INDICATIONS, TECHNIQUES AND OUTCOMESJournal of Urology, 2001